2015
DOI: 10.1021/acssynbio.5b00147
|View full text |Cite
|
Sign up to set email alerts
|

Orthogonal Modular Gene Repression in Escherichia coli Using Engineered CRISPR/Cas9

Abstract: The progress in development of synthetic gene circuits has been hindered by the limited repertoire of available transcription factors. Recently, it has been greatly expanded using the CRISPR/Cas9 system. However, this system is limited by its imperfect DNA sequence specificity, leading to potential crosstalk with host genome or circuit components. Furthermore, CRISPR/Cas9-mediated gene regulation is context dependent, affecting the modularity of Cas9 based transcription factors. In this paper we address the pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
80
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 63 publications
(83 citation statements)
references
References 38 publications
0
80
0
Order By: Relevance
“…CRISPRi holds great promise for a wide range of applications in microorganisms, including bacterial cell growth control [35], genetic screen [25, 36], synthetic biology module development [37, 38] or metabolic networks control in various microorganisms such as E. coli [24, 39, 40], mycobacteria [41], Bacillus subtilis [42], Corynebacterium glutamicum [43], Clostridium beijerinckii [44], yeast [45] and cyanobacteria [7]. In particular, a number of recent studies have exploited CRISPRi to regulate the metabolic pathways in E. coli for enhanced production of various biotechnological products including poly(3-hydroxybutyrate- co -4-hydroxybutyrate) [23], terpenoid [8], pinosylvin [46], flavonoid [47] and mevalonate [48].…”
Section: Discussionmentioning
confidence: 99%
“…CRISPRi holds great promise for a wide range of applications in microorganisms, including bacterial cell growth control [35], genetic screen [25, 36], synthetic biology module development [37, 38] or metabolic networks control in various microorganisms such as E. coli [24, 39, 40], mycobacteria [41], Bacillus subtilis [42], Corynebacterium glutamicum [43], Clostridium beijerinckii [44], yeast [45] and cyanobacteria [7]. In particular, a number of recent studies have exploited CRISPRi to regulate the metabolic pathways in E. coli for enhanced production of various biotechnological products including poly(3-hydroxybutyrate- co -4-hydroxybutyrate) [23], terpenoid [8], pinosylvin [46], flavonoid [47] and mevalonate [48].…”
Section: Discussionmentioning
confidence: 99%
“…The repression strength is strongly dependent on the position with respect to the target promoter as well as the nature of promoter itself [7,8,10,11]. In prokaryotes , repression of up to 1000-fold was achieved when targeting dCas9 to either DNA strand within a promoter or to the non-template DNA strand downstream [7,8,10,1518].…”
Section: Transcriptional Regulation With Crispr-cas9mentioning
confidence: 99%
“…Chromatin state also affects dCas9 DNA binding: it is much weaker within condensed chromatin regions, therefore very good match between sgRNA and target DNA sequence is required [9,46,52]. Further studies of dCas9 and specificity-improved Cas9 proteins [53,54] in the aforementioned contexts will inform further development of computational algorithms [11,43,51,52,55] that incorporate these effects to precisely select the types and amounts of sgRNAs that are most appropriate to specific applications.…”
Section: Transcriptional Regulation With Crispr-cas9mentioning
confidence: 99%
See 2 more Smart Citations